<DOC>
	<DOCNO>NCT01473641</DOCNO>
	<brief_summary>This study characterise frequency specific insertion- , localization- removal-related event clinically significant consequence thereof among Nexplanon user US routine clinical use .</brief_summary>
	<brief_title>Nexplanon Observational Risk Assessment Study ( NORA )</brief_title>
	<detailed_description>Nexplanon subdermal contraceptive implant contain progestogen etonogestrel . It provide contraceptive protection three year . In addition progestogen , Nexplanon contain barium sulfate Next Generation Implanon Applicator ( NGIA ) . Nexplanon develop facilitate correct insertion implant use NGIA , extend diagnostic modality localization implant make radiopaque visible via X-ray image X-ray Computerized Tomography ( CT ) . A large , descriptive , prospective , non-interventional , observational cohort study plan follow cohort new user contraceptive implant Nexplanon . Women recruit health care professional complete Nexplanon Clinical Training Program . Baseline follow-up information collect via self-administered questionnaire . Data analysis include characterize frequency specific insertion- , localization- removal-related event via point-estimates event rate well 95 % confidence interval . The impact potential prognostic factor analyze use multivariate regression model and/or stratified analysis .</detailed_description>
	<mesh_term>Etonogestrel</mesh_term>
	<criteria>Women prescribe new Nexplanon implant Women capable understanding major aspect study complete selfadministered questionnaire English Women willing sign inform consent form</criteria>
	<gender>Female</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Etonogestrel</keyword>
	<keyword>Contraceptive implant</keyword>
	<keyword>Safety</keyword>
</DOC>